{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:29:35Z","timestamp":1792096175683,"version":"4.4.0"},"reference-count":34,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Prolactinomas are the most common pituitary adenomas, comprising 30\u201350% of such tumors. These adenomas cause hyperprolactinemia, leading to decreased fertility, reduced energy and libido, and galactorrhea. Diagnosing and treating prolactinomas in adolescents present unique challenges, as symptoms may be confused with age-related developmental variations. This case report explores the outcomes of early surgical intervention in an adolescent with a prolactinoma. Materials and Methods: A 14-year-old female presented delayed menarche and absent pubertal development. Initial evaluation revealed hyperprolactinemia (228.37 ng\/mL) with normal estradiol levels. Initial management through observation was adopted, but persistent amenorrhea and severe headaches prompted further investigation. Magnetic resonance imaging revealed a cystic pituitary mass with apoplexy. Due to concerns regarding delayed puberty and the need for rapid normalization of prolactin levels, the patient underwent transsphenoidal surgery. Results: After operation, prolactin levels normalized, menarche occurred within three months, and secondary sexual characteristics developed within eight months. Pathology confirmed a pituitary adenoma with a high Ki-67 index (15%). Conclusions: Early surgical intervention for prolactinomas in adolescents can achieve successful biochemical remission and resolution of endocrine symptoms. Adolescents, particularly those with a high Ki-67 index and potential resistance to dopamine agonists, may benefit from prompt surgical management, resulting in improved clinical outcomes and complete tumor resection.<\/jats:p>","DOI":"10.3390\/medicina60081345","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T03:43:28Z","timestamp":1724039008000},"page":"1345","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Feasibility of Early Surgical Treatment for Adolescent Patients with Prolactinoma: A Case Report and Literature Review"],"prefix":"10.3390","volume":"60","author":[{"given":"Yu-Hung","family":"Tsai","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Chung Shan Medical University Hospital, Taichung 40201, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7998-6607","authenticated-orcid":false,"given":"Chi-Ruei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung 40705, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ting","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan"},{"name":"School of Medicine, College of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se-Yi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Chung Shan Medical University Hospital, Taichung 40201, Taiwan"},{"name":"School of Medicine, College of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s10143-023-02033-0","article-title":"Surgery as first-line treatment for prolactinoma? Discussion of the literature and results of a consecutive series of surgically treated patients","volume":"46","author":"Ottenhausen","year":"2023","journal-title":"Neurosurg. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jama.2016.19699","article-title":"Diagnosis and treatment of pituitary adenomas: A review","volume":"317","author":"Molitch","year":"2017","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1046\/j.1365-2265.2003.01748.x","article-title":"Clinical presentation and outcome of pituitary adenomas in teenagers","volume":"58","author":"Venturino","year":"2003","journal-title":"Clin. Endocrinol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/BF03343820","article-title":"Pituitary adenomas in childhood and adolescence. Clinical analysis of 10 cases","volume":"24","author":"Visentin","year":"2001","journal-title":"J. Endocrinol. Investig."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2265.1994.tb02557.x","article-title":"Age-related and gender-related occurrence of pituitary adenomas","volume":"41","author":"Mindermann","year":"1994","journal-title":"Clin. Endocrinol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11060-013-1354-5","article-title":"Epidemiology and etiopathogenesis of pituitary adenomas","volume":"117","author":"Aflorei","year":"2014","journal-title":"J. Neurooncol"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Andereggen, L., Tortora, A., Schubert, G.A., Musahl, C., Frey, J., Luedi, M.M., Mariani, L., Beck, J., and Christ, E. (2023). Prolactinomas in adolescent and elderly patients\u2014A comparative long-term analysis. Front. Surg., 10.","DOI":"10.3389\/fsurg.2023.967407"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1530\/eje.1.02030","article-title":"Diagnosis and management of pituitary tumours in the elderly: A review based on personal experience and evidence of literature","volume":"153","author":"Minniti","year":"2005","journal-title":"Eur. J. Endocrinol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/EO-21-0038","article-title":"DA therapy for prolactinomas: Do we need to rethink the place of surgery in prolactinoma management?","volume":"2","year":"2022","journal-title":"Endocr. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1210\/clinem\/dgz144","article-title":"Surgery as a viable alternative first-line treatment for prolactinoma patients. A systematic review and meta-analysis","volume":"105","author":"Najafabadi","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1530\/EJE-10-0519","article-title":"Pituitary adenomas in childhood, adolescence and young adulthood: Presentation, management, endocrine and metabolic outcomes","volume":"163","author":"Steele","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e14380","DOI":"10.1097\/MD.0000000000014380","article-title":"Clinical characteristics and surgical outcome of prolactinoma in patients under 14 years old","volume":"98","author":"Zhao","year":"2019","journal-title":"Medicine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000497331","article-title":"Surgery for prolactinomas to date","volume":"109","author":"Buchfelder","year":"2019","journal-title":"Neuroendocrinology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11102-023-01313-8","article-title":"How to manage intolerance to DA in patients with prolactinoma","volume":"26","author":"Stumpf","year":"2023","journal-title":"Pituitary"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0033-3182(10)70718-0","article-title":"Management of psychosis associated with a prolactinoma: Case report and review of the literature","volume":"51","author":"Ali","year":"2010","journal-title":"Psychosomatics"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1530\/EJE-18-0682","article-title":"Psychological effects of DA treatment in patients with hyperprolactinemia and prolactin-secreting adenomas","volume":"180","author":"Ioachimescu","year":"2019","journal-title":"Eur. J. Endocrinol."},{"key":"ref_17","first-page":"dgz076","article-title":"Impulse control disorders in dopamine agonist-treated hyperprolactinemia: Prevalence and risk factors","volume":"105","author":"Baranoff","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Hinojosa-Amaya, J.M., Johnson, N., Gonz\u00e1lez-Torres, C., Varlamov, E.V., Yedinak, C.G., McCartney, S., and Fleseriu, M. (2020). Depression and impulsivity self-assessment tools to identify dopamine agonist side effects in patients with pituitary adenomas. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.579606"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40478-015-0229-8","article-title":"Histological criteria for atypical pituitary adenomas\u2014Data from the German pituitary adenoma registry suggests modifications","volume":"3","author":"Miermeister","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00006123-199601000-00024","article-title":"Proliferative activity and invasiveness among pituitary adenomas and carcinomas: An analysis using the MIB-1 antibody","volume":"38","author":"Thapar","year":"1996","journal-title":"Neurosurgery"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00000478-198609000-00003","article-title":"The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: Application to surgical neuropathology","volume":"10","author":"Burger","year":"1986","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jcp.52.2.107","article-title":"Ki-67 labelling index and invasiveness among anterior pituitary adenomas: Analysis of 103 cases using the MIB-1 monoclonal antibody","volume":"52","author":"Mastronardi","year":"1999","journal-title":"J. Clin. Pathol."},{"key":"ref_23","first-page":"104","article-title":"High Ki-67 expression is associated with prolactin secreting pituitary adenomas","volume":"17","author":"Corlan","year":"2017","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0090-3019(97)00102-X","article-title":"Clinical features and growth fractions of pituitary adenomas","volume":"48","author":"Yonezawa","year":"1997","journal-title":"Surg. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3346\/jkms.2005.20.3.489","article-title":"Clinical significance of Ki-67 labeling index in pituitary macroadenoma","volume":"20","author":"PPaek","year":"2005","journal-title":"J. Korean Med. Sci."},{"key":"ref_26","first-page":"199","article-title":"Ki-67 and clinical correlations in patients with resistant prolactinomas","volume":"50","author":"Lu","year":"2020","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000497205","article-title":"Aggressive and malignant prolactinomas","volume":"109","author":"Olarescu","year":"2019","journal-title":"Neuroendocrinology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13256-023-03820-5","article-title":"Macroprolactinoma with secondary resistance to DA: A case report and review of the literature","volume":"17","author":"Tng","year":"2023","journal-title":"J. Med. Case Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/JCMA.0000000000000584","article-title":"Treatment of hyperprolactinemia: A single-institute experience","volume":"84","author":"Chen","year":"2021","journal-title":"J. Chin. Med. Assoc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3803\/EnM.2014.29.3.280","article-title":"Early prediction of long-term response to cabergoline in patients with macroprolactinomas","volume":"29","author":"Lee","year":"2014","journal-title":"Endocrinol. Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11102-010-0261-4","article-title":"Effect of dopaminergic drug treatment on surgical findings in prolactinomas","volume":"14","author":"Menucci","year":"2011","journal-title":"Pituitary"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.3892\/etm.2016.3122","article-title":"Effects of preoperative bromocriptine treatment on prolactin-secreting pituitary adenoma surgery","volume":"11","author":"Cao","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11102-005-5086-1","article-title":"Surgical outcomes in hyporesponsive prolactinomas: Analysis of patients with resistance or intolerance to dopamine agonists","volume":"8","author":"Hamilton","year":"2005","journal-title":"Pituitary"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Vermeulen, E., D\u2019haens, J., Stadnik, T., Unuane, D., Barbe, K., Van Velthoven, V., and Gl\u00e4sker, S. (2020). Predictors of dopamine agonist resistance in prolactinoma patients. BMC Endocr. Disord., 20.","DOI":"10.1186\/s12902-020-0543-4"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/8\/1345\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:38:44Z","timestamp":1760110724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/8\/1345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,19]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["medicina60081345"],"URL":"https:\/\/doi.org\/10.3390\/medicina60081345","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,19]]}}}